About ANGLE
ANGLE is a world leading liquid biopsy company with sample to answer solutions.
ANGLE’s proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

ANGLE has launched a product for the research use market and has an In-vitro Diagnostic Devices Directive CE Mark for the indicated clinical use. The FDA clearance process is currently underway for the clinical market in the US.